Cargando…

Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation

BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a significant disease pandemic. Dhaka City alone has contributed about one-third to the total COVID-19 cases in Bangladesh. Globally, patients with infectious diseases, including COVID-19, experience stigma. There was no quantitative estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kibria, Md. Golam, Islam, Taslima, Islam, Md. Tajul, Kabir, Russell, Ahmed, Shakil, Sultana, Papia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548314/
https://www.ncbi.nlm.nih.gov/pubmed/36221262
http://dx.doi.org/10.7717/peerj.14092
_version_ 1784805408367443968
author Kibria, Md. Golam
Islam, Taslima
Islam, Md. Tajul
Kabir, Russell
Ahmed, Shakil
Sultana, Papia
author_facet Kibria, Md. Golam
Islam, Taslima
Islam, Md. Tajul
Kabir, Russell
Ahmed, Shakil
Sultana, Papia
author_sort Kibria, Md. Golam
collection PubMed
description BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a significant disease pandemic. Dhaka City alone has contributed about one-third to the total COVID-19 cases in Bangladesh. Globally, patients with infectious diseases, including COVID-19, experience stigma. There was no quantitative estimate of stigma experienced by patients with COVID-19 in the country. Therefore, this study aimed to assess the prevalence of stigma and its associated factors among patients with COVID-19 in Dhaka. METHODS: A cross-sectional study was conducted among 384 respondents aged 18 years or older who had been hospitalized or had stayed at home and were tested negative 15 days to 6 months before the day of data collection. Data collection was done through in-person and telephone interviews using a semi-structured survey questionnaire. A 15-item COVID-19-related stigma scale questionnaire was used to assess stigma. Binary logistic regression analysis was performed to identify the predictors of stigma. RESULTS: More than half (53.1%) of the respondents experienced stigma when they were COVID-19 positive. Females were at a 3.24 times higher risk of experiencing stigma than their male counterparts. Respondents from the 60+ age group and 40–59 age group were 63.0% and 48.0% less likely to experience stigma than those from the 18–39 age group. Non-hospitalised patients had 1.67 times higher odds of facing stigma than those hospitalised. CONCLUSIONS: This study reported a high prevalence of stigma among the patients with COVID-19 in Dhaka City. The current evidence base of stigma experience among patients with COVID-19 offers a solid foundation for creating effective strategies and policies and designing appropriate interventions to counter stigma, which will improve the psychological well-being of patients with COVID-19 in Bangladesh.
format Online
Article
Text
id pubmed-9548314
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-95483142022-10-10 Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation Kibria, Md. Golam Islam, Taslima Islam, Md. Tajul Kabir, Russell Ahmed, Shakil Sultana, Papia PeerJ Infectious Diseases BACKGROUND: Coronavirus disease 2019 (COVID-19) has become a significant disease pandemic. Dhaka City alone has contributed about one-third to the total COVID-19 cases in Bangladesh. Globally, patients with infectious diseases, including COVID-19, experience stigma. There was no quantitative estimate of stigma experienced by patients with COVID-19 in the country. Therefore, this study aimed to assess the prevalence of stigma and its associated factors among patients with COVID-19 in Dhaka. METHODS: A cross-sectional study was conducted among 384 respondents aged 18 years or older who had been hospitalized or had stayed at home and were tested negative 15 days to 6 months before the day of data collection. Data collection was done through in-person and telephone interviews using a semi-structured survey questionnaire. A 15-item COVID-19-related stigma scale questionnaire was used to assess stigma. Binary logistic regression analysis was performed to identify the predictors of stigma. RESULTS: More than half (53.1%) of the respondents experienced stigma when they were COVID-19 positive. Females were at a 3.24 times higher risk of experiencing stigma than their male counterparts. Respondents from the 60+ age group and 40–59 age group were 63.0% and 48.0% less likely to experience stigma than those from the 18–39 age group. Non-hospitalised patients had 1.67 times higher odds of facing stigma than those hospitalised. CONCLUSIONS: This study reported a high prevalence of stigma among the patients with COVID-19 in Dhaka City. The current evidence base of stigma experience among patients with COVID-19 offers a solid foundation for creating effective strategies and policies and designing appropriate interventions to counter stigma, which will improve the psychological well-being of patients with COVID-19 in Bangladesh. PeerJ Inc. 2022-10-06 /pmc/articles/PMC9548314/ /pubmed/36221262 http://dx.doi.org/10.7717/peerj.14092 Text en © 2022 Kibria et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Infectious Diseases
Kibria, Md. Golam
Islam, Taslima
Islam, Md. Tajul
Kabir, Russell
Ahmed, Shakil
Sultana, Papia
Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation
title Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation
title_full Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation
title_fullStr Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation
title_full_unstemmed Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation
title_short Stigma and its associated factors among patients with COVID-19 in Dhaka City: evidence from a cross-sectional investigation
title_sort stigma and its associated factors among patients with covid-19 in dhaka city: evidence from a cross-sectional investigation
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548314/
https://www.ncbi.nlm.nih.gov/pubmed/36221262
http://dx.doi.org/10.7717/peerj.14092
work_keys_str_mv AT kibriamdgolam stigmaanditsassociatedfactorsamongpatientswithcovid19indhakacityevidencefromacrosssectionalinvestigation
AT islamtaslima stigmaanditsassociatedfactorsamongpatientswithcovid19indhakacityevidencefromacrosssectionalinvestigation
AT islammdtajul stigmaanditsassociatedfactorsamongpatientswithcovid19indhakacityevidencefromacrosssectionalinvestigation
AT kabirrussell stigmaanditsassociatedfactorsamongpatientswithcovid19indhakacityevidencefromacrosssectionalinvestigation
AT ahmedshakil stigmaanditsassociatedfactorsamongpatientswithcovid19indhakacityevidencefromacrosssectionalinvestigation
AT sultanapapia stigmaanditsassociatedfactorsamongpatientswithcovid19indhakacityevidencefromacrosssectionalinvestigation